Axie Infinity
AXS
Below: live crypto price for Axie Infinity (AXS), a 1-year chart, 8 indicators (RSI, MACD, Bollinger, MA, EMA, Stochastic, ATR, Volume), and a compare mode. Add to your portfolio, star to your watchlist, or set a price alert in one place.
Axie Infinity (AXS) trades at 1.01 USD.
- Prev close
- $1.04
- Volume (24h)
- $120.68K
- Market cap
- $177.38M
- Currency
- USD
Score
35/ 100 · Weak
- Market cap rank—
- Momentum35
- Supply—
- Community—
Composite of public market data. Informational only — not investment advice.
Trend projection
Where the recent trend points if it continues.
- +5 bars
- 1.0291 +1.79%
- +20 bars
- 1.0546 +4.31%
- +60 bars
- 1.0646 +5.30%
- +120 bars
- 1.065 +5.34%
Linear-regression continuation — not a prediction, not investment advice. ±1σ ≈ 68% range · ±2σ ≈ 95% range: ±0.0807 USD.
Interpretation
Composite signals look weak. Price sits near the lower third of the recent range, trend is sloping upward.
Descriptive observation — not investment advice.
Score breakdown
Raw values behind each pillar so you can see what the composite is reading.
- Momentum35/100
Momentum looks weak — driven by 30-day change (1.61%).
30-day change:1.61% - Community—
Community looks mixed — driven by Social channels (0).
Social channels:0
Derived from public market data — informational, not investment advice.
Price report
How this asset has actually moved over the last 400 days.
Where the price sits between the window low and high.
- Volatility (annualised)
- 112.6%
- Max drawdown
- -71.5%
- Below period high
- -66.3%
- Best day
- +72.06%
- Worst day
- -23.21%
- Up days
- 47%
- Current streak
- 1 up
- Typical day swing
- 7.9%
- Volume vs average
- -73%
Spread of returns. Higher means larger swings in both directions.
Worst peak-to-trough fall inside the window.
Current price against the highest point in the window.
Share of days that closed above the one before.
Average high-to-low spread within a single day.
Last 10 days against the whole window.
Descriptive statistics over past prices — not a forecast and not investment advice.
Reference levels
Fibonacci retracements and extensions across the recent range.
Reference only — not investment advice.
These coordinates describe past-trade clustering, not where to buy or sell. Do your own research before any trade.
Levels derived from: 1.4547 high → 0.86 low · 60 bars
- ResistanceFib +161.8% extensionnot reached2.4169 USD+139.06% from current
- ResistanceFib +100% extensionnot reached2.0494 USD+102.71% from current
- ResistanceFib +61.8% extensionnot reached1.8222 USD+80.24% from current
- ResistanceFib +27.2% extensionnot reached1.6165 USD+59.89% from current
- ResistanceFib 23.6% retracementtested 2×1.3144 USD+30.01% from current
- ResistanceFib 38.2% retracementtested 9×1.2275 USD+21.42% from current
- ResistanceFib 50% midpointtested 13×1.1574 USD+14.48% from current
- ResistanceFib 61.8% retracementtested 10×1.0872 USD+7.53% from current
- Current1.011 USD
- SupportFib 78.6% retracementNearesttested 9×0.9873 USD-2.35% from current
- SupportFib −27.2% extensionnot reached0.6982 USD-30.94% from current
- SupportFib −61.8% extensionnot reached0.4925 USD-51.29% from current
- SupportFib −100% extensionnot reached0.2653 USD-73.76% from current
How to read this
We take the highest and lowest price of the last 60 bars and cut the gap between them at the classic Fibonacci ratios (23.6%, 38.2%, 50%, 61.8%, 78.6%), plus extensions beyond both ends.
“Tested N×” counts how many of those 60 bars actually traded through the level. A level price has crossed many times is one the market has repeatedly agreed on; a level at 0 is pure geometry the price has never reached.
This is a map of where trading has already happened — not a forecast and not a signal. Price moves through these levels all the time.
Buy AXS on
Recent news
- BCRF Launches $100 Million Venture Program for Breast Cancer: NYSE Content UpdateCNW Group2d ago
- BCRF Launches $100 Million Venture Program for Breast Cancer: NYSE Content UpdatePR Newswire2d ago
- BCRF Launches $100 Million Venture Program for Breast Cancer: NYSE Content UpdatePR Newswire2d ago
- FAF Trading at a Discount to Industry at 1.12X: Time to Buy or Hold?Zacks3d ago
- 3 Reasons to Avoid AXS and 1 Stock to Buy InsteadStockStory4d ago
- 1 Profitable Stock with Exciting Potential and 2 Facing ChallengesStockStory5d ago
- BofA Adjusts Price Target on Axis Capital to $121 From $131, Keeps Neutral RatingMT Newswires6d ago
- Axis Capital Poised for Better-Than-Market Growth With Multiple Drivers, UBS SaysMT Newswires16d ago
Related
Other assets in this category.
Learn the terms
Live discussion
Sign in to join the discussion.
- No comments yet. Be the first.